NK-101

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNK-101
Drug Alias Namecyclin dependent kinase inhibitor (Neurokin)NK-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase inhibitors
TargetsCyclin-dependent kinase
Therapy Area/IndicationsBrain Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeurokin SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeurokin SA
Active IndicationsN/A
Inactive IndicationsBrain Injuries

Other Information

ATC CodeN/A
Related LinksN/A